The PI3K/AKT/mTOR pathway plays a crucial role in cellular processes and is frequently dysregulated in cancers, including nephroblastoma (Akbarzadeh et al., 2021; Luo et al., 2022; Tian et al., 2022; Yu et al., 2022). Here, AKT1 is linked to cancer.